Javid Yadegar
Internal Medicine · Brooklyn, NYNPI 1588750467
Payments from drug & device makers
Across 73 payments — averaging $18.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$337
- Novo Nordisk$206
- Bayer$85
- AstraZeneca$81
- Boehringer Ingelheim$79
- GSK$62
- plus $465 from 14 others
What the payments were for
- Food & beverage$1,30399%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 19 | $337 |
| Novo Nordisk | 11 | $206 |
| Bayer | 3 | $85 |
| AstraZeneca | 5 | $81 |
| Boehringer Ingelheim | 4 | $79 |
| GSK | 3 | $62 |
| Amarin Pharma, Inc. | 3 | $62 |
| Astellas Pharma US Inc | 3 | $57 |
| Sanofi-aventis U.S. LLC | 3 | $57 |
| Ironwood Pharmaceuticals, Inc | 3 | $45 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $36 |
| Pfizer | 2 | $32 |
| Lilly USA, LLC | 2 | $32 |
| Althera Pharmaceuticals LLC | 4 | $26 |
| Novartis | 1 | $25 |
| Gilead | 1 | $25 |
| Merck | 1 | $24 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| Alnylam Pharmaceuticals Inc. | 1 | $13 |
| EMD Serono, Inc. | 1 | $12 |
How this compares
$1,315 in reported general payments places this provider in the 75th percentile of 9,771 internal medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 21 | $23,023 |
| JardianceEmpagliflozin | 24 | $16,184 |
| LinzessLinaclotide | 22 | $15,660 |
| Diclofenac Epolamine | 24 | $15,429 |
| KerendiaFinerenone | 21 | $14,604 |
| JanumetSitagliptin Phos/Metformin Hcl | 12 | $12,979 |
| TrulicityDulaglutide | 13 | $12,685 |
| FarxigaDapagliflozin Propanediol | 19 | $11,718 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 16 | $10,060 |
| TradjentaLinagliptin | 13 | $8,713 |
| Naproxen-Esomeprazole MagNaproxen/Esomeprazole Mag | 12 | $8,545 |
| JanuviaSitagliptin Phosphate | 13 | $8,443 |
| XareltoRivaroxaban | 11 | $7,681 |
| EntrestoSacubitril/Valsartan | 11 | $7,400 |
| EliquisApixaban | 11 | $6,291 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $79 | $24,89737 claims |
| Novo NordiskOzempic | $206 | $23,02321 claims |
| MerckJanumet, Januvia | $24 | $21,42225 claims |
| AbbVieLinzess | $337 | $15,66022 claims |
| AstraZenecaFarxiga, Symbicort | $81 | $14,89533 claims |
| BayerKerendia | $85 | $14,60421 claims |
| Lilly USA, LLCTrulicity | $32 | $12,68513 claims |
| GSKTrelegy Ellipta | $62 | $10,06016 claims |
| NovartisEntresto | $25 | $7,40011 claims |
| PfizerEliquis | $32 | $6,29111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in Brooklyn
- Bruce BergerBrooklyn$3.4M
- Nelly CohenBrooklyn$2.8M
- Jorge SerjeBrooklyn$1.3M
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- David DoveEast Hampton$12.3M
- Robert CupeloEast Syracuse$10.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.